Background: Obstetric airway guidelines recommend preoxygenation in preparation for general anaesthesia to achieve end-tidal oxygen concentrations (etO 2 ) of !90%, and mention the potential use of high-flow humidified nasal oxygen (HFNO). We investigated the new HFNO technique (Optiflow™) in term pregnant women. Methods: Seventy-three term participants underwent a 3 min HFNO protocol (30 L min À1 for 30 s, and then 50 L min À1 for
The latest airway management guidelines by the Obstetric Anaesthetists' Association and the Difficult Airway Society recommend preoxygenation in pregnant women in preparation for general anaesthesia to achieve an end-tidal oxygen concentration (etO 2 ) of !90% within 3 min. 1 This recommendation is based on historical data that suggest that 95% of pregnant women will achieve optimal preoxygenation within 2 min of normal tidal breathing from a standard circuit and a correctly fitting face mask. 2 There has been much interest in the role for high-flow humidified nasal oxygen (HFNO) in the peri-anaesthesia period for pregnant women after impressive results in the non-pregnant population. 3 This new technique of preoxygenation and apnoeic oxygenation may have the potential to improve safety for pregnant women undergoing general anaesthesia. 4 Physiological changes in pregnancy result in increased incidence of difficult airway management and failed intubation. The incidence of failed tracheal intubation has not changed over the last four decades, with failed intubation occurring in 2.6 per 1000 anaesthetics and one death occurring every 90 failed intubations. 5 Rightfully so, the Obstetric
Anaesthetists' Association and the Difficult Airway Society have emphasised the importance of adequate preoxygenation of pregnant women before the induction of anaesthesia to prolong safe apnoea time to mitigate periods of hypoxaemia if airway management is difficult. Whilst there is likely great value from the apnoeic oxygenation component of HFNO, there is no current evidence in the literature to show that this technique achieves adequate preoxygenation in pregnant women. The adequacy of preoxygenation is typically quantified as the extent of denitrogenation of functional residual capacity. 6 The current recommended preoxygenation practice before general anaesthesia for Caesarean section is to achieve an end-tidal oxygen percent of 90% or more. 1 Data suggest that most anaesthetists aim to achieve this with at least 3 min of normal tidal volume breathing of 100% oxygen. 1 Adequate preoxygenation with HFNO would facilitate hands-free preoxygenation and a seamless transition to apnoeic oxygenation. This would not only liberate members of the anaesthetic team to perform other tasks, but also avoid the need to change from face mask to high-flow nasal cannulae and attempt to mask-ventilate pregnant women who have a higher risk of aspiration. We believe that these would all be benefits especially when facing the high risk situation of an emergency general anaesthesia Caesarean section. 7 Studies that have investigated preoxygenation using highflow nasal oxygen (separate to apnoeic oxygenation) in nonpregnant patient groups report comparable efficacy between high-flow humidified nasal preoxygenation and face mask preoxygenation. 8e10 Pillai and colleagues 8 have shown that etO 2 after 3 min of high-flow humidified nasal preoxygenation in healthy volunteers breathing with closed mouths were noninferior to face mask preoxygenation. Ng and colleagues 9 and
Heinrich and colleagues 10 reported comparable arterial partial pressure of oxygen values after high-flow humidified nasal preoxygenation in neurosurgical and bariatric patients, respectively. Other studies investigating the use of high-flow nasal oxygen for preoxygenation and apnoeic oxygenation in rapid sequence induction have shown longer safe apnoea times when high-flow nasal oxygen was used. 11, 12 There are no current studies investigating preoxygenation of pregnant women using HFNO. Based on these findings, we would expect that high-flow humidified nasal preoxygenation should achieve a similar frequency of successful preoxygenation (defined as etO 2 !90%) to that of face mask preoxygenation. Historical data suggest that this frequency in pregnant women is 95%. We conducted a prospective study to determine the proportion of women who achieve optimal preoxygenation (etO 2 !90% within 3 min) using the new high-flow nasal preoxygenation technique, and to determine acceptability and comfort levels of nasal and face mask preoxygenation. 13 Our primary aim was to determine the proportion of women who achieved an etO 2 !90% [mean and 95% confidence interval (CI)] using the high-flow humidified technique. Our secondary aims were to determine the proportion of women who achieved an etO 2 !80% (mean and 95% CI), to assess changes in fetal heart rate before and after the oxygenation, to examine the association of BMI to etO 2 achieved with preoxygenation, and to determine the comfort levels of and preference for nasal and face mask preoxygenation.
Methods
After ethics approval (The Royal Women's Hospital, Parkville, VIC, Australia, HREC 16/16), trial registration with the Australian New Zealand Clinical Trials Registry (ACTRN 12616000531415p), recruitment, and informed written consent, 73 healthy (ASA physical status classification 2) pregnant women (age 18e40 yr; gestational age !36 weeks) underwent the study. The exclusion criteria were significant nasal pathology, severe cardiac or respiratory disease, pre-eclampsia or sepsis (ASA classification 3 or 4), and women in labour. Each woman was weighed before being positioned on a hospital bed in an optimally ramped position, defined as the external auditory meatus in a horizontal line with sternum using the Troop Elevation Pillow ® (Marlin Medical, Bayswater
North, VIC, Australia) ( Supplementary Fig. S1 ) and with a right lateral pelvic wedge to minimise aortocaval compression. Baseline physiological variables of maternal heart rate, blood pressure, and oxygen saturation (SpO 2 ), and fetal heart rate, were measured before undergoing the study protocol. BMI was calculated from the weight (kg) measured at the time of the study and the height measured at first hospital booking visit.
After baseline physiological variables were measured, and while breathing room air (21% fractional inspired oxygen), a tightly fitting face mask, connected to an anaesthetic circuit and anaesthetic machine, was applied by the investigator, and a good seal and ideal fitting was determined by observing
Editor's key points
In pregnant women undergoing general anaesthesia, appropriate preoxygenation is recommended so that the end-tidal oxygen concentration (etO 2 ) becomes greater than or equal to 90% within 3 min. High-flow humidified nasal oxygen is known to be as effective as conventional preoxygenation using a face mask in non-pregnant patients, but its efficacy has not been assessed in pregnant women. was instructed to take deep breaths with a closed mouth as much as possible. At the end of 3 min, each woman was asked to hold her breath in inspiration, while the nasal cannulae were rapidly removed and the tightly fitting face mask (connected to 6 L min À1 air 100% inspired oxygen concentration) was applied. Each woman was then asked to exhale normally and breathe normally for four breaths, and each etO 2 was measured by the end-tidal gas analyser on the anaesthetic machine (patient gas module gas analyser with PATO oxygen sensor, Primus® anaesthesia machine Dr€ ager, Lü beck, Germany). The first breath etO 2 was used for the primary outcome measurement. 6 Peak oxygen saturation values were also recorded. Fetal heart rate was measured at the end of the procedure. Data points were manually entered into a case report form in real time. Video recordings of the anaesthetic machine monitor were taken during the change from HFNO to face mask in case any data points were unable to be manually recorded in real time. Videos were stored in a passwordprotected mobile device. Comfort levels of the standard face mask and the high-flow nasal cannulae were assessed using a 10-point Likert scale, and women were asked which of the two devices they preferred regarding comfort. After the study procedure, each woman continued with her normal activities for that day.
Data were analysed using SPSS Statistics Version 24 (IBM Corporation, Chicago, IL, USA). Data are presented as mean and standard deviation (SD), median (quartiles) (lowest and highest values), or number and percentage. Linear regression and Pearson correlation coefficient with 95% CI were used to examine the relationship between BMI and expired oxygen concentration. Wilcoxon matched-pairs signed-rank test was used to compare comfort scores between the face mask and nasal prongs. Mean differences, 95% CIs, and two-sided Pvalues are given with a significance level alpha of 0.05. Strength of evidence statements was used to correspond to Pvalues: <0.001, very strong evidence; 0.001 to <0.01, strong evidence; 0.01e0.05, evidence; and >0.05, no evidence. The sample size calculation used historical data from Russell and colleagues, 2 
Results
Seventy-four women were recruited and 73 completed the study. One woman found HFNO too uncomfortable and did not complete the protocol. There were no other complications recorded.
Participant characteristics are shown in Table 1 . The resting physiological variables, expired oxygen concentrations, and fetal heart rate changes are shown in Table 2 . Fortyfour (60%; 95% CI: 54e66%) women achieved the recommended etO 2 ; P¼0.34; 95% CI: e0.9 to 2.6 beats min À1 ). Figure 1 shows the etO 2 with first four breaths after preoxygenation with Optiflow. Figure 2 shows the relationship between term BMI and the first etO 2 value after preoxygenation. There is evidence that the concentration of expired oxygen attained after 3 min of preoxygenation decreases as the BMI increases (Pearson correlation coefficient: e0.26; 95% CI: e0.46 to e0.03; P¼0.027). increase in BMI the concentration of expired oxygen attained decreases by 3%. Figure 3 compares the comfort scores between the face mask and nasal prongs. There was no evidence of a difference in median [inter-quartile range (IQR); range: lowest to highest value] comfort scores between the face mask (median: 6; IQR: 5e8; range: 3e10) and the nasal prongs (median: 6; IQR: 5e8; range: 2.5e10) (median difference: 1; P¼0.40; 95% CI: e0.4 to 1.0); however, 41 (56%; 95% CI: 35e47%) women preferred the nasal cannula to the face mask. 
Discussion
This study examined the use of HFNO as a preoxygenation strategy in term pregnant women. There are three key findings of this study. The first is that HFNO does not achieve comparable preoxygenation (etO 2 !90%) to face mask preoxygenation in term pregnant women. Our results suggest that Optiflow preoxygenation is inadequate for term pregnant women using our study protocol. Using the standard preoxygenation protocol of 30 L min À1 for 30 s, and then 50 L min À1 for the next 150 s, only 60% of women achieved the recommended expired oxygen concentration of 90% or greater with high-flow nasal cannula. We propose possible explanations. This preoxygenation protocol was originally recommended by the Optiflow manufacturer before new evidence in the nonpregnant population. Other investigators have found that preoxygenation using Optiflow at higher flow rates achieved equivalent blood gas results compared with face mask preoxygenation. 8, 11 From our current study, we predict that pregnant women may achieve better preoxygenation at higher flows and greater time than was used in this study. Our study participants, whilst actively encouraged to breathe with their mouths closed, were not mandated to do so. Studies have now shown that Optiflow oxygenation 8 and level of continuous positive airway pressure delivered 14 are decreased when the mouth is open. Furthermore, anatomical and physiological changes in pregnancy affect the parturient's airway with congestion of nasal mucosa and airway structure oedema. It has also been shown that the incidence of sleep-disordered breathing (similar to obstructive sleep apnoea) is increased in pregnancy. 15 These factors may change the in vivo aerodynamics of HFNO in the pregnant woman, and decrease the delivered inspired concentration of oxygen and continuous positive airway pressure compared with use in the nonpregnant individual. We recognise the need for further research to develop a preoxygenation protocol with HFNO that specifically targets adequate levels of denitrogenation in term pregnant women. Functional residual capacity decreases in pregnancy by approximately 20%. In the term pregnant woman lying supine, functional residual capacity commonly decreases below closing capacity. 16 Thus, although it should be easier and faster to denitrogenate the pregnant woman's smaller functional residual capacity, closure of small airways during tidal breathing may restrict access of oxygen to parts of the lung. Current literature reveals variable statistics in terms of the proportion of pregnant women who preoxygenate adequately, with values ranging from 75% to 95% in small sample sizes. 2, 17 This raises larger questions of whether we truly understand the real percentage of pregnant women who can and will achieve the preoxygenation target of etO 2 of 90% and, more importantly, the predictors of failure of our current practice. The larger number of overweight, obese, and superobese pregnant women makes this issue even more pertinent.
The second key result of this study is that we found an association between BMI and the first etO 2 level, such that the higher the BMI the lower the etO 2 value. This may be the case as a result of the exacerbation of all the aforementioned mechanical and physiological issues. Obese patients are also more reliant on positive end-expiratory pressure for optimal preoxygenation. 17 Thus, the effect of mouth opening whilst using HFNO may be more marked in this group. The third key finding is that of the comfort of the nasal cannulae. More than 50% of women preferred the nasal cannula to the face mask for preoxygenation, demonstrating that this technique is acceptable to pregnant women who experience physiological changes to their nasal and pharyngeal mucosa.
Our study was limited by the fact that the participants were volunteers and not about to undergo urgent surgery with the physical and emotional stress that accompanies it. One of the main proposed applications for this technique is urgent general anaesthetic Caesarean section. 4 In this scenario, one would predict that oxygen consumption of the parturient would be increased, and thus, preoxygenation may be even less adequate than demonstrated. Effective denitrogenation may not only increase etO 2 , but it may also prolong the time to hypoxaemia. This study did not examine apnoeic oxygenation, so inferences about time to oxygen desaturation cannot be made. Our data did not record the participants' ventilatory frequency before, during, and after undergoing the protocol, and thus, we were unable to determine whether ventilatory frequency and secondarily tidal volumes may affect the preoxygenation success. This study was also not designed to compare directly the efficacy of Optiflow preoxygenation to face mask preoxygenation. Thus, we were unable to comment on inferiority or vice versa at this point, as previous studies investigating preoxygenation in term pregnant women have had variable success rates and small sample sizes.
Future studies are required to delineate if there is an ideal format of timing and flow rates of HFNO that will achieve adequate preoxygenation in pregnant women. Pregnant women who are overweight, obese, and super-obese should also be studied specifically to determine if HFNO will have better efficacy if patients maintain mouth closure throughout preoxygenation. This technology may be of largest benefit to this subgroup. Future studies should examine the role of HFNO as an apnoeic oxygenation technique in term pregnant women.
High-flow humidified nasal preoxygenation is comfortable in term pregnant women; however, our results suggest that using the standardised protocol does not achieve a clinically acceptable level of preoxygenation (etO 2 !90% in 95% of pregnant women) to justify its use in term pregnant women as a preoxygenation technique. Further studies are required, especially in women with larger BMI, to optimise the technique for term pregnant women.
